
Role of Sleep Apnea in the Neuropsychological Function in Down Syndrome People
Down SyndromeThis is the first study about Neuropsychological function and OSAS in Taiwan. Although the correlation between OSAS and neuropsychological abnormalities had been reported, it is worth to understand more about the detailed domains that involved in our cohort. After this, investigators can dissect the cause of mental retardation in DS and help for further treatment strategies.

Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome
Irritable Bowel SyndromeThe purpose of this study is to investigate the effect of pectin, a kind of soluble dietary fiber, on clinical symptoms, gut microbiota and the immune status in patients with diarrhea-predominant irritable bowel syndrome

Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents
Irritable Bowel SyndromeFunctional Gastrointestinal DisordersThis randomized controlled trial aims to evaluate the treatment effects of an internet-delivered CBT-program for adolescents with irritable bowel syndrome.

A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic...
Nephrotic SyndromeTo demonstrate that the treatment effect in refractory nephrotic syndrome of MZR is non-inferior to that of standard therapy CTX through analyzing overall remission rate after treatment.

Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders
Devic's SyndromeDevic's Neuromyelitis Optica3 moreNeuromyelitis optica (NMO) is a demyelinating and degenerative disorder of the central nervous system affecting vision and brain and spinal cord function which leads to accumulating disability with a 5 year-mortality of approximately 30%. Survivors are typically left with severe morbidity secondary to blindness, quadriparesis and respiratory failure. No agent has been found to be highly effective in halting disease activity.Based on recent outcomes of Multipotent mesenchymal stromal cells in autoimmune diseases including multiple sclerosis, and based on the mechanisms of neuromyelitis optica, the investigators anticipate that mesenchymal stem cells transplantation may provide lasting disease stability for neuromyelitis optica patients.

The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients...
Irritable Bowel Syndromethe laxative-probiotic sequential treatment might reduce the symptoms of IBS and alter the fecal microbiota of the patients in a more robust manner .

Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
Hematopoietic Syndrome Due to Acute Radiation SyndromeThe purpose of this study is to determine whether HemaMax is safe and well tolerated to support efficacy under FDA's Animal Rule to reduce the morbidity and mortality associated with the hematopoietic syndrome of acute radiation syndrome.

Immunotherapy and Paraneoplastic Neurological Syndromes
Paraneoplastic Neurological SyndromesParaneoplastic Neurological Syndromes (PNS) are rare remote effects of cancer, not directly attributed to mass lesions, metastases, infections, ischemia, coagulopathy, metabolic disruptions or tumour treatment. Currently, PNS treatment is mostly limited to tumour treatment. Because of an initial inflammatory stage early in the evolution of the PNS several immunotherapy modalities have been tried. Intravenous human immunoglobulins could be expected to provide a stabilization or even improvement of PNS, if administered early enough to prevent permanent neuronal damage.

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's...
Primary Sjögren's SyndromeThis study did evaluate the safety,tolerability and preliminary therapeutic efficacy of multiple doses of intravenous infusion of CFZ533 monoclonal antibody in patients with primary Sjögren's syndrome(pSS)

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Irritable Bowel Syndrome Characterized by ConstipationThis is a randomized, 12-week, double-blind, placebo-controlled, dose-ranging study in patients with IBS-C.